Enriched Signalling Pathways in Venetoclax-Relapsed Chronic Lymphocytic Leukemia (CLL) Cells and Targeting Using a Protac-Based Bcl-2/Bcl-Xl DegraderDaisy Diaz Rohena, Deepa Sampath, Bailey Slawin et al.|Blood|2023Cited by 1